Quarterlytics / Healthcare / Biotechnology / ImageneBio Inc

ImageneBio Inc

IMA · NASDAQ Healthcare
Claim this profile
Ticker IMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 10
Overview Research & Coverage Annual Reports FAQ Peers Earnings Calls Financials News Management

Business description

Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis

San Diego, CA
Is this your company?
Claim profile to control your coverage, no call required.
Company facts
TickerIMA
ExchangeNASDAQ
Sector Healthcare
Industry Biotechnology
Employees10